Criteria for a positive sweat test in children (sweat sodium greater than 60 mmol/L and sweat chloride greater than 70 mmol/L) were investigated in a series of adults aged between 18 and 40 years using the standard Gibson and Cooke technique of pilocarpine iontophoresis. A significant number of non-cystic fibrosis adults had sweat sodium values greater than 60 mmol/L whereas a concentration of chloride greater than 70 mmol/L always discriminated adults with cystic fibrosis from normal adults and those with chest disease not due to cystic fibrosis. In all cases of adult cystic fibrosis the sweat sodium concentration was greater than 80 mmol/L. The Na:CI ratio and sum ofNa and CI provided additional helpful criteria in distinguishing between adults with and without cystic fibrosis.
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It is a widely held view that the sweat test cannot be used to diagnose cystic fibrosis (CF) with certainty in adults due to the high sweat Na and CI in normal adults, although a normal result can be used to exclude the diagnosis. The fludrocortisone suppression test' has been recommended to improve the diagnostic value of the sweat test for adults but involves the need for repeat testing and there may be drug side effects such as oedema. ' This study was designed to test adults against criteria for a positive result in children using our standard sweat testing technique. In our experience a sweat test in a child is considered positive if Na~60 mmol/L and Cl~70 mmol/L. The result is considered equivocal if only one of these criteria is satisfied. When this occurs the Na:CI ratio and sum ofNa and Cl may be valuable. We are not aware of any other study where both sweat Na and CI have been measured in adults using the standard Gibson and Cooke technique.' SUBJECTS Three groups of adult volunteers each aged 18 to 40 years were recruited into the study. The groups comprised patients with CF, patients undergoing investigation for chest disease not due to CF and normal adults (20 in each group). All Correspondence; Ms S K Hall.
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patients attended an adult chest clinic and were recruited by date of birth on a voluntary basis. Cystic fibrosis had been diagnosed in childhood by the presence of typical clinical features and a positive sweat test and the normal adults were all laboratory personnel with no history of chest or digestive disease. The chest clinic patients had a variety of disorders including asthma, bronchiectasis' and haemoptysis. The study received approval from East Birmingham Hospital ethical committee; all volunteers read an explanatory leaflet describing the study, the sweat test procedure and signed a consent form. The information was reinforced verbally prior to carrying out the sweat test. All sweat tests were performed by one operator (SKH) between July 1986 and April 1989.
METHOD

Sweat production was achieved with the Gibson and
Cooke technique of pilocarpine iontophoresis and analysed as previously described" but modified by increasing the concentrations of pilocarpine to 0·4 % and of magnesium sulphate to 0·1 M. The collection period was reduced to 20min (or less if the paper was visibly wet). A minimum sweat rate of I g/m 2 / min corresponding to approximately 50 mg sweat was required. We have shown (unpublished data) that repeat sweat test results included. No tests had to be rejected on the basis of unsatisfactory quality control results but two tests failed (one normal control and one adult with chest disease) due to inadequate sweat production. In these cases further volunteers were recruited. Subjects and results are summarized in Table I .
Although the sensitivity of sweat Na~60mmoljL was 100 % the specificity was only 80 % in normal adults and 65 % in adults with chest disease. In contrast the sensitivity and specificity of sweat CI~70 mmoljL was 100 %. In the four normals with sodium~60 mmol/L, all had CI < Na and CI < 70mmoljL. Na:CI ratios and the sums ofNa + CI discriminated all CF from all normals and adults with chest disease. BO :
on patients whose sweat rate on initial testing fell between I and 2 gjm 2jmin were not significantly different from those when the second sweat rate was~2 gjm 2jmin, the latter corresponding to approximately 100 mg sweat.
A sweat test quality assurance solution of sodium (50 rnmol/L) and chloride (100 mmoljL) was pipetted onto a weighed filter paper and put through all steps of the analysis with each of the 26 batches of tests. The quality assurance solution gave a mean sodium of 51·2 mmol/L (CV = 2,4%) and mean chloride 100'2mmoljL (CV = 3·4 %), n = 26.
RESULTS
Sweat Na and CI concentrations in the three groups are shown in Fig Previously most work has related only to sodium' or sodium and potassium" changes with age. We have been unable to find age-related reference ranges for sweat chloride.
There has been little work on the value and interpretation of sweat test electrolytes in normal or CF adults. Di Sant'Agnese and Davis? defined a positive sweat test in adults as Na and CI > 50-60mmoljL 'similar to ... children'. This study shows that a Na in this range discriminates Kirk and Westwood" measured Na alone and found that seven of 29 (24 %) non-CF patients aged between 12 and 61 had sweat Na concentrations of > 70 mmolfL and eight (28 %) had results 50-70 mmolfL. We found 40 % of the non-CF subjects had Na 50-70 mmol/L and 5 % > 70 mmol/L, The increase of sweat sodium concentration with age may be more pronounced than of sweat chloride perhaps due to decreasing aldosterone concentrations as suggested by Kirk and Westwood.' Our finding that the criterion for Na for a positive sweat test in children was not 100 % specific in adults, whereas the criterion for Cl remained valid, may corroborate this. In our limited experience we found that although a sweat Na of~80mmoifL could be used alone as a criterion for a positive sweat test in adults, the discrimination between patients with CF and others was less clear cut than for a sweat CI of 70 mmol/L, We would be confident that results of CI~70 mmolfL, Na~60 and a N a: CI ratio of 1·2 or less in the same test would be consistent with the diagnosis ofCF in an adult aged 18-40 years. Use of these data should remove the need for multiple sweat testing before and after treatment with fludrocortisone' in adults in this age group. We would always recommend the analysis of both Na and CI in sweat as each acts as a quality assessment of the other ion and interpretation of both results together is easily performed if expressed graphically.
